New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Akero Therapeutics, Inc.
Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq ・ Market Cap: Small
New Purchase Insider
CEO Recent Sales
Top Executive Recent Sales
Regular Sale Insiders
High Sales Frequency
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 1 / 55 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 1 / 6 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 200,000 / 1,143,183 200,000 / 20,785 |
| VALUE PURCHASED/SOLD Transaction Average | $9,600,000 / $40,162,899 $9,600,000 / $730,235 |
| PURCHASE RANGE | $9,600,000 - $9,600,000 |
| SALE RANGE | $12,882.16 - $4,420,260.05 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
1 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
3 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
100%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
33.04%
DIRECTORS
66.96%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.368 0.295 |
VALUE GINI INDEX Sector Average | 0.384 0.288 |
Akero Therapeutics, Inc. 1Y Trade Transactions